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Pardee, 1969; Holley, 1972), lectin agglutin-
ability (Burger and Goldberg, 1967; Ozanne
and Sambrook, 1971), cell surface components
(Kijmoto and Hakamori, 1971; Hynes and
Bye, 1974) and more recently, the leukaemia-
associated nuclear antigen (Klein et al., 1974).
In this talk, the variable expression of
surface antigens with cell growth were
illustrated and evidence presented for the
occurrence of " division membrane antigens "
in man. These antigens can only be detected
at the cell surface during cell division and
may therefore contribute to antigenic
differences between tumour cells (dividing)
and normal adult cells (resting).
Division membrane antigens specific for
human lymphoid cells were first recognized
using heteroantisera raised in rabbits against
human thymocytes or Burkitt lymphoma
cells (Thomas and Phillips, 1973). After
absorptions with normal adult tissues, sera
were specific for thymocytes and T lympho-
blasts or B lymphoblasts and Ig-positive
lymphoid cell lines. Recently, it was shown
that cold agglutinin, anti-i sera recognize a
determinant unique to dividing human cells,
which has been designated the il antigen
(Thomas, 1975). This antigen is present on
the surface membrane of various cell types
including lymphoblasts, fibroblasts, erythro-
blasts, and thymocytes and absent from
normal adult tissues. Absorption studies
have shown that the il determinant is
distinct from the il antigens of erythrocytes.
To determine the temporal expression of
division antigens during the life cycle,
cultured lymphoblasts have been fractionated
according to size, and therefore age, by
velocity sedimentation in a zonal rotor.
Rotor fractions were analyzed for the il
antigen or blast-specific antigen and cells
were assigned to a position in the cell cycle
according to size and ability to incorporate
3H-thymidine into DNA. A majority of cell
fractions from the rotor corresponding to the
G1 (or Go) interval were negative for both
specificities, whilst there was an enrichment
of antigen-positive cells at the S and G2
interval. This indicates that surface markers
exist which recognize cells " in cycle ".
The above antigens are present on tumour
cells, embryonic cells, and normal dividing
cells; oncofoetal antigens have been demon-
strated on tumour and embryonic cells, but as
yet no attempt has been made to establish
whether they are re-expressed on normal
dividing cells. Aredivisionantigensoncofoetal
antigens? There still remains a need for
"comparison . .. between the cancer cell and
a normal cell growing equally rapidly ".
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ROLE OF TARGET CELLS IN
DETERMINING LEUKAEMIC
CHARACTERISTICS
L. G. LAJTHA, Christie Hospital and Holt
Radium Institute, Manchester.
The bone marrow cell population may be
described as a " three tier " structure of
interrelated cell populations: (a) the pluri-
potent stem cells, (b) the " committed "
precursor cells, and (c) the maturing " end
line " cells. The inter-linking is in effect
provided by the two differentiation steps
which create populations (b) and (c) respec-
tively, the rate of differentiation, in part at
least, being controlled by the appropriate
population sizes.
Both the " committed " precursor and the
maturing " end line " populations are transit
types of cell populations in the sense that
while they possess proliferative capacity, this
is limited to a varying number (4-10) of cell
cycles. This enables a highly elastic ampli-
fication-depending on demand-in the
transit populations, but only up to the limit
of their proliferation capacity.
Both these transit populations undergo
" age changes " i.e. maturation during their
amplification transit and their rate of
maturation-which thus limits their proli-
feration capacity-can be altered by physio-
logical controlling factors.REPORT OF THE LEUKAEMIA RESEARCH FUND 285
Following leukaemogenic "trans-
formation" the proliferation control is
certainly affected-either directly (as is
likely in the pluripotent stem cells), or
indirectly (e.g. by interfering with the
proliferation limiting maturation processes-
the so-called " suicide maturation "-in the
transit populations).
Differentiation control is also affected on
leukaemic transformation but vestiges of
differentiating capacity may be retained.
Interference with the physiological rates of
maturation processes e.g. slowing down
maturation, also slows down the rate of loss
of " pluripotentialities " (e.g. choice between
granulocytic and monocytic direction).
This potential elasticity of the haemo-
poietic cell system makes the " pinning
down " of the target cells difficult. The
apparent properties of cells in the developed
leukaemic clone(s) may be very misleading
indicators of the precise position of the
target cell in the developmental series.
While it is possible that a relatively " late "
cell develops autonomy, it is equally possible
that very " early " cells retain some differen-
tiation potential even after leukaemic
changes. New in vitro culture methods,
combined with specific cytotoxic mani-
pulation are the necessary tools for the
elucidation of the problem-including the
possible role of intercell interactions in the
leukaemogenic process.
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THE PATTERN OF MALIGNANT
LYMPHORETICULAR CELL PROLI-
FERATION AND ITS RELEVANCE
TO CHEMOTHERAPY*
H. P. WAGNER, Institute for Clinical and
Experimental Cancer Research, Berne.
One model for discussing this topic is the
lymphoid cell population as found in the bone
marrow of children with acute lymphoid
leukaemia (ALL). We use the term
" lymphoid " to designate poorly differen-
tiated cells larger than lymphocytes which
mayor maynothave blast cell characteristics.
In children with ALL usually more than 90%
of the bone marrow cells are lymphoid at the
time of diagnosis. Normal and leukaemic
lymphoid cells cannot be differentiated by
morphologic criteria.
The proliferative characteristics of
lymphoid bone marrow cells (LBMC) have
been investigated in patients with untreated
and relapsing ALL (Mauer, Saunders and
Lampkin, 1969; Killmann, 1972; Wagner,
Cottier and Cronkite, 1972). The following
observations were made: (i) only a- small
percentage of LBMC incorporated 3H-
thymidine after pulse-labelling; (ii) the
percentage of LBMC varied from patient to
patient and according to the stage of the
disease; (iii) the median cell cycle phase
transit times varied from patient to patient
but were longer than those of myelocytes or
red cell precursors; (iv) there was a reciprocal
exchange of cells between the compartment
of large, initially labelled, proliferating
LBMC and the compartment of small,
initially unlabelled LBMC; and (v) the
majority of initially unlabelled small cells
retained the capability to divide.
In patients with untreated ALL single
drug injections produced the following effects
(Lampkin, McWilliams and Mauer, 1972);
(i) corticosteroids and L-asparaginase lysed
proliferating and nonproliferating LBMC and
inhibited the entry of surviving cells into S;
(ii) methotrexate arrested and destroyed cells
in S; (iii) cytosine arabinoside inhibited DNA
synthesis, produced a partial synchronization
ofproliferating cells and apparently recruited
resting cells; (iv) vi'ncristine arrested cells in
mitosis; (v) cyclophosphamide inhibited DNA
synthesis, affected cells in mitosis and
prevented the entrance of cells into S; and
(vi) daunomycin lysed cells, particularly
those in S. Based on these results attempts
were made first to recruit and synchronize
and then to kill 'LBMC with " cell cycle
specific " agents. In view of the variability
of the cell cycle phase transit times of LBMC
in patients with untreated ALL and con-
sidering the inability to differentiate leukae-
mic and normal LBMC, these procedures risk
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